Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Ruchita, Balasubramanian"'
Autor:
Ruchita Balasubramanian, Thomas P Van Boeckel, Yehuda Carmeli, Sara Cosgrove, Ramanan Laxminarayan
Publikováno v:
PLoS Medicine, Vol 20, Iss 6, p e1004178 (2023)
BackgroundHospital-associated infections (HAIs) are an important cause of morbidity and mortality around the world. Many HAIs are caused by drug-resistant bacterial pathogens, but there are major gaps in our understanding of the number of hospital-as
Externí odkaz:
https://doaj.org/article/80f73d37294b4342ab5850809c1bbede
Autor:
Chirag K Kumar, Ruchita Balasubramanian, Stefano Ongarello, Sergio Carmona, Ramanan Laxminarayan
Publikováno v:
PLoS ONE, Vol 17, Iss 7, p e0271103 (2022)
Although COVID-19 vaccines are globally available, waning immunity and emerging vaccine-evasive variants of concern have hindered the international response and transition to a post-pandemic era. Testing to identify and isolate infectious individuals
Externí odkaz:
https://doaj.org/article/0d2628f42ec840f29cb6b2109e288974
Autor:
Ruchita Balasubramanian, Justin Im, Jung-Seok Lee, Hyon Jin Jeon, Ondari D. Mogeni, Jerome H. Kim, Raphaël Rakotozandrindrainy, Stephen Baker, Florian Marks
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 6, Pp 1421-1426 (2019)
Invasive non-typhoidal Salmonella (iNTS) disease has emerged as a major public health concern. Yet, understanding of the global burden is incomplete, limited particularly by the breadth of blood culture-based surveillance systems that are able to acc
Externí odkaz:
https://doaj.org/article/0bfbc693530c40e59155d01df8598271
Autor:
Justin Im, Ruchita Balasubramanian, Moussa Ouedraogo, Lady Rosny Wandji Nana, Ondari D. Mogeni, Hyon Jin Jeon, Tayma van Pomeren, Andrea Haselbeck, Jacqueline Kyungah Lim, Kristi Prifti, Stephen Baker, Christian G. Meyer, Jerome H. Kim, John D. Clemens, Florian Marks, Abdramane Bassiahi Soura
Publikováno v:
Heliyon, Vol 6, Iss 7, Pp e04389- (2020)
Background: Dengue is prevalent in as many as 128 countries with more than 100 million clinical episodes reported annually and four billion people estimated to be at risk. While dengue fever is systematically diagnosed in large parts of Asia and Sout
Externí odkaz:
https://doaj.org/article/59d60461d25e41f5a0af4cf1a558f2bc
Autor:
Ruchita, Balasubramanian, Parastu, Kasaie, Melissa, Schnure, David W, Dowdy, Maunank, Shah, Anthony Todd, Fojo
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 91:144-150
Pre-exposure prophylaxis (PrEP) is a key component in helping to reduce HIV incidence in the United States. Long-acting injectable (LAI) PrEP is a new alternative to oral PrEP; its potential to affect local HIV epidemics remains unclear.The Johns Hop
Autor:
Balasubramanian, Ruchita1 (AUTHOR) ruchitab@alumni.princeton.edu, Van Boeckel, Thomas P.1,2 (AUTHOR), Carmeli, Yehuda3 (AUTHOR), Cosgrove, Sara4 (AUTHOR), Laxminarayan, Ramanan1,5 (AUTHOR)
Publikováno v:
PLoS Medicine. 6/13/2023, Vol. 19 Issue 6, p1-13. 13p. 1 Chart, 2 Graphs, 1 Map.
Autor:
Ruchita Balasubramanian, Justin Im, Andrea Haselbeck, Abdramane Bassiahi Soura, Stephen Baker, Kristi Prifti, Moussa Ouedraogo, Lady Rosny Wandji Nana, Ondari D. Mogeni, Florian Marks, John D. Clemens, Jacqueline Kyungah Lim, Christian Meyer, Hyon Jin Jeon, Jerome H. Kim, Tayma van Pomeren
Publikováno v:
Heliyon
Heliyon, Vol 6, Iss 7, Pp e04389-(2020)
Heliyon, Vol 6, Iss 7, Pp e04389-(2020)
Background Dengue is prevalent in as many as 128 countries with more than 100 million clinical episodes reported annually and four billion people estimated to be at risk. While dengue fever is systematically diagnosed in large parts of Asia and South
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7a30094a06c40e298dae956fd44e940
https://ora.ox.ac.uk/objects/uuid:6eaf2806-312f-4586-aed0-071b3be4df40
https://ora.ox.ac.uk/objects/uuid:6eaf2806-312f-4586-aed0-071b3be4df40
Autor:
Stephanie Hauck, Aditi Sriram, Ruchita Balasubramanian, Jyoti Joshi, Geetanjali Kapoor, Isabel Frost, Arindam Nandi, Emily Schueller, Ramanan Laxminarayan
BackgroundThe rapid spread of COVID-19 globally has prompted policymakers to evaluate the capacity of health care infrastructure in their communities. Many hard-hit localities have witnessed a large influx of severe cases that strained existing hospi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38c7d26ecdfa495839d6c7783d094304
https://doi.org/10.1101/2020.06.16.20132787
https://doi.org/10.1101/2020.06.16.20132787
IntroductionDespite measures such as travel restrictions and lockdowns, the novel coronavirus (SARS-COV-2) is projected to spread across India. Considering that a vaccine for COVID-19 is will not be available soon, it is important to identify populat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a048d6094ec79ff21298207fc1ebb6b
Autor:
Ruchita, Balasubramanian, Justin, Im, Jung-Seok, Lee, Hyon Jin, Jeon, Ondari D, Mogeni, Jerome H, Kim, Raphaël, Rakotozandrindrainy, Stephen, Baker, Florian, Marks
Publikováno v:
Human Vaccines & Immunotherapeutics
Invasive non-typhoidal Salmonella (iNTS) disease has emerged as a major public health concern. Yet, understanding of the global burden is incomplete, limited particularly by the breadth of blood culture-based surveillance systems that are able to acc